FinLogic News | Latest Trends in Blockchain, Stocks & Futures

UK Bonds Left Reeling as Market Shreds Bets on BOE Rate Cuts

(Bloomberg) -- UK government borrowing costs rose to the highest level in decades relative to Germany’s, as traders grew increasingly skeptical over how much more easing the Bank of England will manage to deliver next year.Most Read from BloombergHow California Sees the World, and ItselfHong Kong's Expat Party Hub Reshaped by Chinese InfluxLondon’s Tube Fares Are Set to Rise by 4.6% Next YearThe spread between UK and German 10-year bond yields widened to 229 basis points, the highest on a closin

Quantum Computing Stock Skyrockets Further on NASA Contract

Quantum Computing was awarded a contract by NASA's Goddard Space Flight Center to use its entropy quantum optimization machine to help the space agency's imaging.

Investors' allocation to US stocks hits record high amid 'super-bullish sentiment': BofA survey

Increased optimism about growth in the US economy and new policies from the Trump administration have investors growing increasingly bullish on US stocks heading into 2025.

Building Bridges in Crypto: Bybit Sparked Dialogues and Joined Industry Leaders at Bitcoin MENA

Dubai, United Arab Emirates, December 17th, 2024, Chainwire Bybit, the world’s second-largest cryptocurrency exchange by trading volume, proudly participated in Bitcoin...

Nvidia stock slumps into a correction and Broadcom sinks despite its 'Nvidia moment'

Nvidia (NVDA) stock is in correction territory, and rival chipmaker Broadcom’s (AVGO) late-year boost took a hit Tuesday morning.

Viridian Therapeutics sees stock soar after Phase III TED success

The company’s chronic thyroid eye disease treatment, veligrotug, was able to reduce eye bulge by 56% compared with placebo.

How would a U.S. bitcoin strategic reserve work?

By Gertrude Chavez-Dreyfuss and Lisa Pauline Mattackal WASHINGTON (Reuters) -Bitcoin hit a record high above $107,000 on Monday after President-elect Donald Trump reiterated plans...

Pfizer Stock Rises as 2025 Outlook in Line With Expectations

Pfizer shares rose Tuesday morning after the pharmaceutical company affirmed its full-year 2024 projections and issued 2025 revenue and adjusted profit guidance in line with analysts' estimates.

Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday?

On Tuesday, Biomea Fusion Inc. (NASDAQ:BMEA) revealed topline results from the ongoing COVALENT-111 study of icovamenib in patients with type 2 diabetes (T2D). Icovamenib was investigated in three different dosing arms with a primary follow-up after 26 weeks: Arm A at 100mg QD (once daily) for 8 weeks, Arm B at 100mg QD for 12 weeks, and Arm C at 100 mg QD for 8 weeks and 100mg BID (twice daily) for 4 weeks. Also Read: FDA Removes Clinical Hold On Biomea Fusion’s Early-Stage Trials For Potential